New Drug's first human test: is it safe?
NCT ID NCT07324642
Summary
This early-stage study tested a new drug called KINE-101 in 24 healthy volunteers to see if it's safe and how it behaves in the body. Participants received daily intravenous doses for one week at three different strength levels, while some received a placebo. The main goal was to check for side effects and measure how long the drug stays in the bloodstream.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chungbuk National University Hospital
Cheongju-si, North Chungcheong, 28644, South Korea
Conditions
Explore the condition pages connected to this study.